[HTML][HTML] Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Y Matsuzaka, R Yashiro - Vaccines, 2023 - mdpi.com
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines.
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Despite several issues concerning storage, stability, effective period, and side effects, viral …
[PDF][PDF] Extracellular Vesicle-Based SARS-CoV-2 Vaccine. Vaccines 2023, 11, 539
Y Matsuzaka, R Yashiro - 2023 - pdfs.semanticscholar.org
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines.
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Y Matsuzaka, R Yashiro - Vaccines, 2023 - pubmed.ncbi.nlm.nih.gov
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines.
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Y Matsuzaka, R Yashiro - Vaccines, 2023 - search.proquest.com
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines.
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Extracellular Vesicle-Based SARS-CoV-2 Vaccine.
Y Matsuzaka, R Yashiro - Vaccines, 2023 - search.ebscohost.com
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines.
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Despite several issues concerning storage, stability, effective period, and side effects, viral …
[HTML][HTML] Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Y Matsuzaka, R Yashiro - Vaccines, 2023 - ncbi.nlm.nih.gov
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines.
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Extracellular vesicle-based SARS-CoV-2 vaccine.
Y Matsuzaka, R Yashiro - 2023 - cabidigitallibrary.org
Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines.
Despite several issues concerning storage, stability, effective period, and side effects, viral …
Despite several issues concerning storage, stability, effective period, and side effects, viral …